RBMY1C
RNA-binding motif protein, Y chromosome, family 1 member C
Also known as: RBY1C_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for RBMY1C in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
496 residues, UniProt reviewed canonical sequence.
>P0DJD4|RBMY1C
1 MVEADHPGKL FIGGLNRETN EKMLKAVFGK HGPISEVLLI KDRTSKSRGF AFITFENPAD
61 AKNAAKDMNG KSLHGKAIKV EQAQKPSFQS GGRRRPPASS RNRSPSGSLR SARGSRGGTR
121 GWLPSHEGHL DDGGYTPDLK MSYSRGLIPV KRGPSSRSGG PPPKKSAPSA VARSNSWMGS
181 QGPMSQRREN YGVPPRRATI SSWRNDRMST RHDGYATNDG NHPSCQETRD YAPPSRGYAY
241 RDNGHSNRDE HSSRGYRNHR SSRETRDYAP PSRGHAYRDY GHSRRDESYS RGYRNRRSSR
301 ETREYAPPSR GHGYRDYGHS RRHESYSRGY RNHPSSRETR DYAPPHRDYA YRDYGHSSWD
361 EHSSRGYSYH DGYGEALGRD HSEHLSGSSY RDALQRYGTS HGAPPARGPR MSYGGSTCHA
421 YSNTRDRYGR SWESYSSCGD FHYCDREHVC RKDQRNPPSL GRVLPDPREA CGSSSYVASI
481 VDGGESRSEK GDSSRYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RBMY1C can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
OntologyGO
Biological processes
- mRNA processing
- positive regulation of mRNA splicing, via spliceosome
- regulation of RNA splicing
- RNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RBMY1C in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RBMY1C as an antibody target. Whether an autoantibody or antibody against RBMY1C could matter depends on whether native RBMY1C is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RBMY1C is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RBMY1C as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...